| Literature DB >> 32232621 |
Rosalyn C Zimmermann1, Danny R Welch2,3.
Abstract
Despite high mortality rates, molecular understanding of metastasis remains limited. It can be regulated by both pro- and anti-metastasis genes. The metastasis suppressor, breast cancer metastasis suppressor 1 (BRMS1), has been positively correlated with patient outcomes, but molecular functions are still being characterized. BRMS1 has been implicated in focal adhesion kinase (FAK), epidermal growth factor receptor (EGFR), and NF-κB signaling pathways. We review evidence that BRMS1 regulates these vast signaling pathways through chromatin remodeling as a member of mSin3 histone deacetylase complexes.Entities:
Keywords: BRMS1; Breast cancer metastasis suppressor 1; Epigenetic(s); Histone deacetylase; mSin3
Mesh:
Substances:
Year: 2020 PMID: 32232621 PMCID: PMC7487056 DOI: 10.1007/s10555-020-09871-0
Source DB: PubMed Journal: Cancer Metastasis Rev ISSN: 0167-7659 Impact factor: 9.264